Drawing for ABC IVF

USPTO serial 79220046

ABC IVF

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SONNEBORN, TRICIA L
Law office
TMO LAW OFFICE 110 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with ABC IVF?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic reagents for in vitro use; biochemical for in vitro use/diagnostics; biochemicals namely, polypeptides for in vitro research use; biochemicals namely, precursors for in vitro genetic engineering use; diagnostic reagents for in-vitro use other than medical; biochemicals for in vitro and in vivo scientific use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; chemicals for use in the purification of proteins for in vitro use; reagents for in-vitro laboratory use other than for medical or veterinary purposesACTIVE—
005In vitro preparations for medical use; fertility enhancement preparations; dietary and nutritional supplements; fertility enhancement preparations; injectable preparations for the treatment of sexual impotency; preparations for the treatment of fertility diseases; in vitro preparations for predicting ovulation; in vitro diagnostic preparations for medical purposes; preparations for the diagnosis of pregnancy; chemical preparations for the in-vivo diagnosis of pregnancy; medicated preparations for the diagnosis of pregnancy; pregnancy testing preparations; reagents for use in diagnostic pregnancy tests; ovulation test kits; preparations for detecting mutation in prion genes for medical purposes; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical preparations for hydrating the skin during pregnancy; preparations for the diagnosis of ovulation; in vitro gender prediction test kits; in vitro preparations for predicting ovulationACTIVE—
009Downloadable electronic publications, magazines, brochures, leaflets; computer software; computer application software; downloadable computer software accessible via the internet and wireless devices enabling the recording and examination of information relating to fertility and infertility; scientific apparatus and instruments; teaching apparatus and instrumentsACTIVE—
010Surgical, medical apparatus and instruments; diagnostic apparatus for pregnancy testingACTIVE—
016Printed matter, publications; planners; charts for the purposes of recording and examining information relating to personal fertility and infertility; printed instructional and educational material relating to medical services and healthcare services; printed instructional and educational material relating to fertility, infertility and pregnancy; printed instructional and educational material relating to gynaecologyACTIVE—
035Management of health care clinics; advertising; business administrationACTIVE—
041Education and training services; training and educational services relating to medical and healthcare services; training and educational services relating to fertility, infertility and pregnancy; training and educational services relating to gynaecologyACTIVE—
042Clinical research, clinical trials; scientific and technological services and research in the field of infertility treatment and fertility disordersACTIVE—
044In vitro fertilisation services; in vitro fertilisation segmentation services, medical clinic services; medical services in the field of in vitro fertilization; medical consultations; medical services and healthcare services; medical and healthcare services relating to fertility, infertility and pregnancy; medical and healthcare services for women and couples; gynaecological services for women; human healthcare services; medical care and medical analysis services relating to the field of infertility treatment and fertility disorders; human fertility treatment services; herbalism services; alternative medicine services; sperm-bank services; medical testing in relation to anti-mullerian hormones; human sperm donation services; human embryo freezing services; medical services in relation to intra-uterine insemination; medical services relating to tubal patency testing; medical services relating to hysteroscopy; hormone treatment servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 24, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 7, 2022CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Jun 26, 2022CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Jun 24, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 11, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 13, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 23, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 26, 2019FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 10, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 10, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 24, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 19, 2019OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 3, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 3, 2019OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 10, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 10, 2018MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 10, 2018ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 5, 2018ATRVATTORNEY REVIEW COMPLETED—
May 29, 2018LIMELIMITATION FROM THE IB - REQUEST EXAM REVIEW—
May 18, 2018LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Dec 23, 2017RFNTREFUSAL PROCESSED BY IB—
Dec 5, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 5, 2017RFRRREFUSAL PROCESSED BY MPU—
Nov 21, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 20, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 14, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 13, 2017DOCKASSIGNED TO EXAMINER—
Nov 9, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 7, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance